Evidence map›Paper›PMID 24465370›Full record

Trial reportPloS one2014

Network analysis reveals distinct clinical syndromes underlying acute mountain sickness.

David P Hall, Ian J C MacCormick, Alex T Phythian-Adams, Nina M Rzechorzek, David Hope-Jones, Sorrel Cosens, Stewart Jackson, Matthew G D Bates, David J Collier, David A Hume and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. The 2018 Lake Louise Acute Mountain Sickness Score.High altitude medicine & biology · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

David P HallRoyal Air Force Centre of Aviation Medicine, RAF Henlow, Beds, United Kingdom ; Apex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom.
Ian J C MacCormickApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom.
Alex T Phythian-AdamsApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom.
Nina M RzechorzekApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom ; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
David Hope-JonesApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom.
Sorrel CosensApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom.
Stewart JacksonApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom.
Matthew G D BatesApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom ; Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom.
David J CollierWilliam Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
David A HumeDivision of Genetics and Genomics, Roslin Institute, Edinburgh, United Kingdom.
Thomas FreemanDivision of Genetics and Genomics, Roslin Institute, Edinburgh, United Kingdom.
A A Roger ThompsonApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom ; Academic Unit of Respiratory Medicine, Department of Infection and Immunity, University of Sheffield, Sheffield, United Kingdom.
John Kenneth BaillieApex (Altitude Physiology Expeditions), c/o Dr. J. K. Baillie, Critical Care Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, United Kingdom ; Division of Genetics and Genomics, Roslin Institute, Edinburgh, United Kingdom.
Edinburgh Royal Infirmary · GBUniversity of Edinburgh · GBGenomics (United Kingdom) · GBNewcastle Hospitals - Campus for Ageing and Vitality · GBRoslin Institute · GBRoyal Air Force College Cranwell · GBWilliam Harvey Research Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/D/20251969Wellcome Trust 090385/Z/09/ZWellcome Trust 101113
6 · The paper itself

Abstract

Acute mountain sickness (AMS) is a common problem among visitors at high altitude, and may progress to life-threatening pulmonary and cerebral oedema in a minority of cases. International consensus defines AMS as a constellation of subjective, non-specific symptoms. Specifically, headache, sleep disturbance, fatigue and dizziness are given equal diagnostic weighting. Different pathophysiological mechanisms are now thought to underlie headache and sleep disturbance during acute exposure to high altitude. Hence, these symptoms may not belong together as a single syndrome. Using a novel visual analogue scale (VAS), we sought to undertake a systematic exploration of the symptomatology of AMS using an unbiased, data-driven approach originally designed for analysis of gene expression. Symptom scores were collected from 292 subjects during 1110 subject-days at altitudes between 3650 m and 5200 m on Apex expeditions to Bolivia and Kilimanjaro. Three distinct patterns of symptoms were consistently identified. Although fatigue is a ubiquitous finding, sleep disturbance and headache are each commonly reported without the other. The commonest pattern of symptoms was sleep disturbance and fatigue, with little or no headache. In subjects reporting severe headache, 40% did not report sleep disturbance. Sleep disturbance correlates poorly with other symptoms of AMS (Mean Spearman correlation 0.25). These results challenge the accepted paradigm that AMS is a single disease process and describe at least two distinct syndromes following acute ascent to high altitude. This approach to analysing symptom patterns has potential utility in other clinical syndromes.

Indexed as

AltitudeMountaineeringSurveys and QuestionnairesAcute DiseaseAdultAltitude SicknessAntioxidantsBoliviaExpeditionsFatigueFemaleHeadacheHumansMalePiperazinesPurinesAntioxidantsPiperazinesPurinesSildenafil CitrateSulfonesVasodilator Agents

Identifiers

PMID24465370
PMCPMC3898916
OpenAlexW2111605665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.